ELCC Highlights - Felip and Barlesi

ELCC Highlights - Felip and Barlesi

This edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC: Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy cohorts CheckMate 9LA -- randomized 719 patients with EGFR/ALK wild type NSCLC to standard chemotherapy or 2 cycles of chemotherapy with nivolumab and Ipilimumab KEYNOTE-407-- randomized squamous NSCLC to carboplatin with choice of nab/ paclitaxel or paclitaxel, and either pembrolizumab or placebo AMG 757-- BiTE: bispecific T-cell engager targeting DLL3 and engaging CD3 CAMEL-sq trial-- phase III randomized trial in patients with advanced squamous NSCLC

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(417)

LCC in Hebrew: WCLC 2026 Highlights

LCC in Hebrew: WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC h...

16 Loka 38min

WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of t...

13 Loka 18min

LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To ad...

9 Loka 37min

LCC in Korean WCLC 2026 Highlights

LCC in Korean WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...

6 Loka 45min

WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and con...

5 Loka 24min

WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and cl...

1 Loka 34min

WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and...

29 Syys 44min

LCC in Czech: WCLC 2026 Highlights

LCC in Czech: WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASL...

24 Syys 10min

Suosittua kategoriassa Tiede

tiedekulma-podcast
utelias-mieli
rss-mita-tulisi-tietaa
rss-duodecim-lehti
rss-hereilla
docemilia
rss-kasvikutsut
rss-vaasan-yliopiston-podcastit
rss-poliisin-mieli
rss-kasvatuspsykologiaa-kaikille